Clinical Trial Update: Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance low-dose oral Navelbine in non-small cell lung cancer patients (Stage IIIB and IV) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Navelbine (vinorelbine)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Non-small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV | Phase 2 | Status: COMPLETED